Molecularly, low-grade serous carcinomas generally have low levels of chromosomal instability and carry frequent mutations in KRAS, BRAF, and ERBB2, while high-grade serous carcinomas tend to have high levels of chromosomal instability and frequently show mutations in TP5310. Here, KRAS is linked to serous adenocarcinoma.